Back to results
US 6,121,319 AGranted
Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
AssigneeAtheroGenics, Inc.
InventorPatricia K. Somers
Life of this patent
Estimating the term…
Abstract
This invention is a method and composition for the inhibition of VCAM-1, and in particular for the treatment of cardiovascular or inflammatory disease, including atherosclerosis, that includes the administration of an effective amount of an ester of probucol.
Claims14
A method for inhibition of VCAM-1 comprising administering to a patient an effective amount of a monoester of probucol or a pharmaceutically acceptable salt thereof.
A method for the treatment of a disease mediated by VCAM-1 comprising administering to a patient an effective amount of a monoester of probucol or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.